Filtered By:
Vaccination: Measles Vaccine
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 1232 results found since Jan 2013.
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
The objectives of this study were to evaluate when patients received MMR vaccine after an HSCT in our care service and if there were reports of any side effects. We retrospectively reviewed the records of HSCT recipients who received at least one MMR dose in our care service, a quaternary teaching hospital in Sao Paulo city, Brazil, from 2017 to 2021. We identified 82 patients: 75.6% (90.1% in the autologous group and 45.1% in the allogeneic group) were vaccinated before 23 months post-transplantation. None reported side effects following the vaccination. Our data support that the MMR vaccination is safe from 12 to 23 mont...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 22, 2023 Category: Tropical Medicine Authors: Bruno Azevedo Randi Eder Gatti Fernandes Hermes Ryoiti Higashino Marta Heloisa Lopes Vanderson Geraldo Rocha Silvia Figueiredo Costa Ana Marli Christovam Sartori Source Type: research
What's in a number? The value of titers as routine proof of immunity for medical students
CONCLUSIONS: The requirement of numerical, non-standardized serologic testing highlights an oversight in medical school admissions documentation. The requirement for quantitative values to demonstrate immunity is not practical from a laboratory standpoint, and is not needed to show individual immunity to these vaccine-preventable diseases. Until a more standardized process is adopted, laboratories will need to provide clear documentation and direction for quantitative titer requests.PMID:36948982 | DOI:10.1016/j.vaccine.2023.03.009
Source: Vaccine - March 22, 2023 Category: Allergy & Immunology Authors: Carmen L Charlton Ashley-Nicole M Bailey L Alexa Thompson Jamil N Kanji Natalie C Marshall Source Type: research
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
The objectives of this study were to evaluate when patients received MMR vaccine after an HSCT in our care service and if there were reports of any side effects. We retrospectively reviewed the records of HSCT recipients who received at least one MMR dose in our care service, a quaternary teaching hospital in Sao Paulo city, Brazil, from 2017 to 2021. We identified 82 patients: 75.6% (90.1% in the autologous group and 45.1% in the allogeneic group) were vaccinated before 23 months post-transplantation. None reported side effects following the vaccination. Our data support that the MMR vaccination is safe from 12 to 23 mont...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 22, 2023 Category: Tropical Medicine Authors: Bruno Azevedo Randi Eder Gatti Fernandes Hermes Ryoiti Higashino Marta Heloisa Lopes Vanderson Geraldo Rocha Silvia Figueiredo Costa Ana Marli Christovam Sartori Source Type: research
Inclusion of vaccination into clinical pathways for COPD and asthma: current challenges and future perspectives in Italy
CONCLUSIONS: Italian CPWs still pay little attention to the topic of vaccinations in patients with COPD and asthma. CPWs are required to be updated in the future being compliant with the national immunization schedule recommendations.PMID:36942681 | DOI:10.19191/EP23.1-2.A521.015
Source: Herpes - March 21, 2023 Category: Infectious Diseases Authors: Rosa Prato Domenico Martinelli Silvia Calabria Carla Maria Irene Quarato Carlo Piccinni Giovanna Elisiana Carpagnano Alessandro Rossi Francesco Blasi Francesca Fortunato Maria Pia Foschino Barbaro Source Type: research
Quantification of waning immunity after measles vaccination - evidence from a seroprevalence study
Am J Epidemiol. 2023 Mar 17:kwad065. doi: 10.1093/aje/kwad065. Online ahead of print.ABSTRACTThe aim of this study was to quantify waning rates from seroprevalence data collected in a study of population with a high vaccination coverage and fixed vaccination schedule. Data were collected during the national Immunologic Survey in the Slovak Republic in 2018. The average waning rate after the first dose (age 1.5 - 10 years) is 9.7% per year from the geometric mean titre (GMT) value 2634 mUI/ml. The average waning rate after the second dose (age 10 - 33 years) is significantly lower, 4.8% per year from the lower GMT value 133...
Source: Am J Epidemiol - March 19, 2023 Category: Epidemiology Authors: Jana Zibolenov á Henrieta Hude čková Zuzana Chladn á Eva Malobick á Martin Nov ák Iveta Waczul íková J án Mikas Adriana Me čochová Source Type: research
Differential coverage for vaccines in the expanded program on immunization (EPI) among children in rural Pakistan
CONCLUSION: Vaccine coverage was low among children in Matiari, Pakistan, and majority received delayed doses. Parents' education status and year of study enrollment was protective against vaccine dropout and delayed vaccination whereas geographical distance from a major road was a predictor. Vaccine promotion and outreach efforts may have had a beneficial impact on vaccine coverage and timeliness.PMID:36933984 | DOI:10.1016/j.vaccine.2023.03.007
Source: Vaccine - March 18, 2023 Category: Allergy & Immunology Authors: Shahira Shahid Sheraz Ahmed Muhammad Farrukh Qazi Rafey Ali Syed Asad Ali Anita K M Zaidi Najeeha T Iqbal Fyezah Jehan Muhammad Imran Nisar Source Type: research
Changes in vaccination administration in Japan
Vaccine. 2023 Mar 16:S0264-410X(23)00282-7. doi: 10.1016/j.vaccine.2023.03.020. Online ahead of print.ABSTRACTThis paper reviews the administration related to vaccination in Japan after the enactment of the Immunization Act in 1948, under which vaccination was implemented mandatory for the public. To enhance the effectiveness of vaccination activities, the government implemented group vaccination, which is convenient for vaccinating recipients all at once. In 1976, Japan established the relief system for health damage after vaccination. While some projects, such as the mass administration of live oral polio vaccine in 1961...
Source: Vaccine - March 18, 2023 Category: Allergy & Immunology Authors: Takashi Nakano Source Type: research
Second Dose Measles Vaccination Utilization and Associated Factors in Jabitehnan District, Northwest Ethiopia
CONCLUSION: Second dose measles vaccination utilization in the district was lower than the national target. Maternal education, distances from vaccination site, information about MCV2, and knowledge about immunization were significantly associated variables with second dose measles vaccination utilization. Therefore, in order to increase the utilization of the second dose of the measles vaccine, improved health education and service expansion to difficult-to-reach areas are required.PMID:36923301 | PMC:PMC10009019 | DOI:10.1177/15593258231164042
Source: Dose Response - March 16, 2023 Category: Drugs & Pharmacology Authors: Aynalem Demewoz Moges Wubie Muluye Gebrie Mengie Esmelealem Mihretu Kassegn Dubie Jara Abiot Aschale Bekalu Endalew Source Type: research
